Millions of prescription eye drop bottles have been recalled across the United States after federal regulators identified a potential contamination issue.
The Food and Drug Administration (FDA) recently classified a nationwide recall of more than 2.5 million bottles of Prednisolone Acetate Ophthalmic Suspension, USP, 1%, manufactured by Lupin Pharmaceuticals, as a Class II recall after the products were found to contain a potential foreign substance.
According to the FDA's enforcement report, the recall involves approximately 2.53 million bottles of prescription prednisolone acetate ophthalmic suspension in 5-milliliter, 10-milliliter and 15-milliliter bottles. Lupin initiated the recall on June 4 and classified as a Class II recall on June 30.
Prednisolone acetate is a corticosteroid eye drop commonly prescribed to reduce inflammation associated with noninfectious eye conditions, including allergies, injuries and inflammation following surgery.
The FDA said the recalled products may contain a foreign substance, although the agency did not specify which material. Patients who have the recalled medication are advised to stop using it and follow instructions provided by the manufacturer or their health care provider regarding replacement or disposal.
Why Sterility Matters for Eye Drops
Unlike medications taken by mouth, eye drops are applied directly to one of the body's most delicate tissues.
Because the eye has limited natural defenses against contaminants introduced through medications, ophthalmic products must be manufactured under strict sterile conditions. Even microscopic particles or microbial contamination can irritate the eye or introduce harmful bacteria or fungi.
Contamination of sterile ophthalmic products can increase the risk of eye infections, inflammation and other complications, particularly in patients with underlying eye disease or those recovering from surgery.
Foreign particles themselves can also damage the eye's surface, potentially scratching the cornea and creating an entry point for infection.
What Can Happen if Contaminated Eye Drops Are Used?
The severity of contamination-related injuries depends on the type of contaminant and the patient's underlying eye health.
Potential complications may include:
- Eye irritation, redness or pain.
- Corneal abrasions or injury caused by foreign particles.
- Bacterial or fungal eye infections.
- Corneal ulcers that can threaten vision.
- Permanent vision loss in severe cases if infections are not treated promptly.
Although the current recall was classified as Class II, where health consequences are generally expected to be temporary or medically reversible, the designation does not eliminate the need for caution.
However, individuals with weakened immune systems, recent eye surgery or existing corneal disease may be especially vulnerable to complications.
Eye Drop Recalls Have Become a Growing Safety Concern
The Lupin recall follows several high-profile eye drop recalls in recent years involving sterility concerns.
In 2023, contaminated artificial tears linked to drug-resistant bacteria resulted in dozens of infections, permanent vision loss and several deaths, prompting increased scrutiny of ophthalmic manufacturing practices and oversight.
Those incidents reinforced a long-standing principle in ophthalmology: because eye medications bypass many of the body's normal protective barriers, even small lapses in manufacturing quality can have disproportionately serious consequences.
As a result, manufacturers of sterile ophthalmic products are subject to rigorous quality control standards designed to minimize contamination risks before products reach pharmacies.
What Patients Should Do
Patients using Prednisolone Acetate Ophthalmic Suspension, USP, 1% should check the bottle's manufacturer, lot number and National Drug Code (NDC) to determine whether their prescription is included in the recall.
Anyone with an affected product should stop using it immediately and contact their prescribing physician or pharmacist about obtaining a replacement. Patients should not discontinue prescribed steroid eye treatment without consulting a health care provider, as untreated eye inflammation may also lead to complications.
People who develop worsening eye pain, redness, blurred vision, increased sensitivity to light or discharge after using eye drops should seek prompt medical evaluation, as these symptoms may indicate an eye infection or corneal injury requiring urgent treatment.
